Quelles nouveautés en contraception féminine ?
- 6 November 2023
- journal article
- editorial
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 52 (1) , 1-2
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and DrospirenoneThe Journal of Clinical Endocrinology & Metabolism, 2022
- Bleeding profile of women with cardiovascular risk factors using a drospirenone only pill with 4 mg over nine cycles compared to desogestrel 0.075 mgGynecological Endocrinology, 2022
- Metabolic and laboratory effects of a progestin-only pill containing drospirenone 4 mg in comparison to desogestrel 75 µg: a double-blind, double-dummy, prospective, randomised studyThe European Journal of Contraception & Reproductive Health Care, 2021
- Estetrol‐Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and RussiaBJOG: An International Journal of Obstetrics & Gynaecology, 2021
- Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parametersContraception, 2020